CVE-2026-51904SuperAGI up to v0.0.14 contains an improper access control vulnerability in the agent execution controller.
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
EPSS puts the chance of exploitation in the next 30 days at 0.41%, higher than 34% of scored CVEs.
SuperAGI up to v0.0.14 contains an improper access control vulnerability in the agent execution controller. In affected source snapshots, create_agent_execution and create_agent_run in superagi/controllers/agent_execution.py accept a caller-supplied agent_id and fail to verify that the referenced agent belongs to the authenticated user's organization. A remote authenticated attacker from one organization can create or start execution records for agents owned by another organization through /agentexecutions/add or /agentexecutions/add_run.
- CVSS
- 9.8 CRITICAL (v3.1, CISA ADP)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-284
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.41% (percentile 34)
- Assigned by
- mitre
- NVD analysis
- Deferred
- Record last updated
- Oct 5, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://gist.github.com/Ro1ME/3f712e2a9f643a08c6c825d25fbfe0e0
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.